Tonix Pharma (TNXP) Tops Q2 EPS by 27c

Tonix Pharma (NASDAQ: TNXP) reported Q2 EPS of ($2.44), $0.27 better than the analyst estimate of ($2.71). Revenue for the quarter came in at $13.54 million versus the consensus estimate of $6.96 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Increasing unusual put volume: CAPR BW AEP NMAX KORU VCX SM YSS HWM MUU WDAY NU